{
  "meta": {
    "title": "Gastro-Intestinal_Tract_Git",
    "url": "https://brainandscalpel.vercel.app/gastro-intestinal-tract-git-229fb0df.html",
    "scrapedAt": "2025-11-29T18:33:57.049Z"
  },
  "questions": [
    {
      "id": 8276,
      "choices": [
        {
          "id": 33071,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">They are pro-drugs and undergo activation gradually</span></span></span></p>"
        },
        {
          "id": 33072,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">From stomach, these quickly reach the parietal cells and enter acid secretory canaliculi and stay there, blocking the secretion of acid for a long time</span></span></span></p>"
        },
        {
          "id": 33073,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">They irreversible inhibit the proton pump molecule </span></span></span></p>"
        },
        {
          "id": 33074,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">They are available as enteric coated capsules, from which drug is gradually released</span></span></span></p>"
        }
      ],
      "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Despite their short half-lives (2 hrs), proton pump inhibitors (PPIs) cause a prolonged suppression of acid secretion (up to 48 hrs) because?</span></span></p>",
      "unique_key": "Q6684452",
      "question_audio": null,
      "question_video": null,
      "map_id": 36300,
      "difficulty_level": "beginner",
      "subjects_id": [
        4
      ],
      "solution": "<p><strong><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. C) They irreversible inhibit the proton pump molecule</span></span></span></strong></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><strong>Proton pump inhibitors (PPIs)</strong> work by binding <strong>irreversibly to the sulfhydryl groups of cysteines </strong>on the<strong> gastric H+, K+ -ATPase </strong>(the proton pump). This <strong>covalent binding</strong> results in the <strong>permanent inactivation of the pump molecules</strong> present at the time of drug administration. <strong>Acid secretion</strong> can only <strong>resume</strong> after <strong>new proton pump molecules</strong> are <strong>synthesized and transported to the luminal</strong> <strong>membrane</strong> of the stomach&rsquo;s <strong>parietal cells.</strong> This mechanism leads to a<strong> prolonged suppression of gastric acid secretion</strong>, lasting<strong> 24 to</strong> <strong>48 hours, </strong>despite the <strong>PPIs&rsquo; short plasma half-lives of 0.5 to 2 hours.</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. They are pro-drugs and undergo activation gradually:</span></strong><span style=\"font-size:12.0pt\"> <strong>Incorrect </strong>because while<strong> PPIs</strong> are indeed <strong>prodrugs </strong>that are activated <strong>within</strong> the acidic environment of the <strong>parietal cells</strong>, the<strong> gradual activation does not </strong>directly contribute to the <strong>prolonged acid</strong> <strong>suppression</strong>. The prolongation comes from the <strong>irreversible inhibition of the pumps.</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. From stomach, these quickly reach the parietal cells and enter acid secretory canaliculi and stay there, blocking the secretion of acid for a long time:</span></strong><span style=\"font-size:12.0pt\"><strong> Incorrect </strong>because<strong> PPIs do not </strong>travel directly from the<strong> stomach to the parietal cells.</strong> They must first be <strong>absorbed from the intestine</strong> and then <strong>distributed to the parietal cells</strong> via the<strong> bloodstream.</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. They are available as enteric coated capsules, from which drug is gradually released:</span></strong><span style=\"font-size:12.0pt\"> <strong>Incorrect </strong>as the<strong> enteric coating </strong>only serves to <strong>protect the drug </strong>from<strong> gastric acid degradation</strong> rather than <strong>prolonging its action </strong>at the <strong>site of the proton pumps.</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><strong>Proton pump inhibitor</strong>s cause <strong>prolonged acid suppression</strong> by<strong> irreversibly binding to</strong> and <strong>inactivating the proton pumps</strong> in the stomach, and <strong>acid secretion </strong>only <strong>resumes </strong>once <strong>new pumps are synthesized and active.</strong></span></span></span></p>",
      "correct_choice_id": 33073,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 8277,
      "choices": [
        {
          "id": 33075,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ranitidine combines with sucralfate and prevents its action</span></span></span></p>"
        },
        {
          "id": 33076,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Combination of these two drugs produces serious side effects like agranulocytosis</span></span></span></p>"
        },
        {
          "id": 33077,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ranitidine increases the gastric pH so sucralfate is not able to act</span></span></span></p>"
        },
        {
          "id": 33078,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Sucralfate inhibits the absorption of ranitidine</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A patient of peptic ulcer was prescribed ranitidine and sucralfate in the morning hours. Why is this combination incorrect?</span></span></p>",
      "unique_key": "Q6825346",
      "question_audio": null,
      "question_video": null,
      "map_id": 36301,
      "difficulty_level": "intermediate",
      "subjects_id": [
        4
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. C) Ranitidine increases the gastric pH so sucralfate is not able to act</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><strong>Sucralfate </strong>is a medication <strong>used to treat</strong> ulcers by forming a<strong> protective barrier over the ulcer site.</strong> It requires an <strong>acidic environment</strong> <strong>(pH &lt; 4)</strong> to <strong>polymerize and function effectively.</strong> <strong>Ranitidine</strong>, an <strong>H2 receptor antagonist,</strong> works by <strong>reducing gastric acid secretion,</strong> thereby <strong>increasing gastric pH</strong>. When these<strong> two drugs</strong> are <strong>administered together,</strong> the<strong> increased pH</strong> caused by <strong>ranitidine </strong>can<strong> prevent</strong> <strong>sucralfate</strong> from <strong>polymerizing and forming </strong>its <strong>protective barrier, rendering it ineffective.</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Ranitidine combines with sucralfate and prevents its action:</span></strong><span style=\"font-size:12.0pt\"><strong> Incorrect </strong>because <strong>ranitidine does not </strong>chemically combine with <strong>sucralfate</strong>; the issue is the<strong> pH environment alteration.</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Combination of these two drugs produces serious side effects like agranulocytosis:</span></strong><span style=\"font-size:12.0pt\"> Incorrect as there is <strong>no</strong> evidence to suggest that <strong>agranulocytosis</strong> is a<strong> common side effect </strong>of combining these<strong> two drugs.</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Sucralfate inhibits the absorption of ranitidine:</span></strong><span style=\"font-size:12.0pt\"><strong> Incorrect </strong>because <strong>sucralfate does not</strong> affect the<strong> absorption of ranitidine;</strong> its primary interaction is with the<strong> gastric pH </strong>affecting its<strong> own mechanism of action.</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><strong>Sucralfate</strong> needs an <strong>acidic environment</strong> to be<strong> effective.</strong> <strong>Co-administration </strong>with <strong>ranitidine,</strong> which <strong>raises gastric pH,</strong> can <strong>impair </strong>the <strong>effectiveness of sucralfate</strong> in treating <strong>ulcers.</strong></span></span></span></p>",
      "correct_choice_id": 33077,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 8284,
      "choices": [
        {
          "id": 33103,
          "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Famotidine</span></span></p>"
        },
        {
          "id": 33104,
          "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Omeprazole</span></span></p>"
        },
        {
          "id": 33105,
          "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Misoprostol</span></span></p>"
        },
        {
          "id": 33106,
          "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ranitidine</span></span></p>"
        }
      ],
      "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 30-year-old pregnant woman has a history of rheumatoid arthritis which has been managed successfully with NSAIDs. However, she has recently visited her general practitioner complaining of burning epigastric pain worsened by food intake. Which of the following ulcer medication is most likely contraindicated in this patient?</span></span></p>",
      "unique_key": "Q7041910",
      "question_audio": null,
      "question_video": null,
      "map_id": 36304,
      "difficulty_level": "intermediate",
      "subjects_id": [
        4
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. C) Misoprostol </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><strong>Misoprostol,</strong> a<strong> prostaglandin E1 analog,</strong> is effective in preventing<strong> NSAID-induced ulcers</strong> due to <strong>its ability to increase gastric mucus</strong> and<strong> bicarbonate production</strong>, thus <strong>enhancing the stomach&#39;s protective lining</strong>. However,<strong> it is contraindicated during pregnancy </strong>as it <strong>stimulates uterine contractions</strong>, which can<strong> lead to miscarriage</strong>. Therefore, it is <strong>not suitable</strong> for use by <strong>pregnant women</strong>, making it the<strong> contraindicated medication</strong> in this scenario.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Famotidine:</span></strong><span style=\"font-size:12.0pt\"><strong> Incorrect </strong>as Famotidine, an <strong>H2 receptor antagonist,</strong> is generally <strong>considered safe</strong> for use <strong>during pregnancy</strong>. It works by <strong>reducing stomach acid</strong> and is <strong>not </strong>known to<strong> harm the fetus.</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Omeprazole:</span></strong><span style=\"font-size:12.0pt\"> <strong>Incorrect </strong>because <strong>Omeprazole</strong>, a<strong> proton pump inhibitor</strong>, is also <strong>used </strong>to manage ulcer symptoms by <strong>reducing</strong> <strong>acid production. </strong>While its <strong>use in pregnancy</strong> should be <strong>cautious, </strong>it is<strong> not</strong> specifically<strong> contraindicated </strong>like <strong>Misoprostol.</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Ranitidine:</span></strong><span style=\"font-size:12.0pt\"><strong> Incorrect</strong> as Ranitidine, another<strong> H2 receptor antagonist,</strong> is typically <strong>safe</strong> for use <strong>during pregnancy. </strong>It works <strong>similarly to Famotidine</strong> by<strong> reducing gastric acid</strong> and is<strong> not </strong>associated with significant <strong>risks </strong>to the <strong>developing fetus.</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><strong>Misoprostol</strong> is <strong>contraindicated in pregnant</strong> patients due to<strong> its potential </strong>to <strong>induce uterine contractions</strong> and <strong>risk</strong> causing <strong>abortion.</strong></span></span></span></p>",
      "correct_choice_id": 33105,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 8274,
      "choices": [
        {
          "id": 33063,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">RANK ligand inhibitor</span></span></span></p>"
        },
        {
          "id": 33064,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">NMDA antagonist</span></span></span></p>"
        },
        {
          "id": 33065,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">NK 1 receptor antagonist</span></span></span></p>"
        },
        {
          "id": 33066,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">5 HT3 antagonist</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Mechanism of action of an aprepitant is?</span></span></span></p>",
      "unique_key": "Q1742514",
      "question_audio": null,
      "question_video": null,
      "map_id": 36299,
      "difficulty_level": "beginner",
      "subjects_id": [
        4
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. C) NK 1 receptor antagonist</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C:</span></strong></span></span></p>\r\n\r\n<p><br />\r\n<span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><strong>Aprepitant</strong> functions as a<strong> neurokinin-1 (NK1) receptor antagonist</strong>. It is primarily used as an<strong> antiemetic </strong>to<strong> prevent delayed</strong> <strong>chemotherapy-induced nausea and vomiting (CINV)</strong>. The drug works by<strong> blocking the binding of substance P</strong>&mdash;a <strong>neuropeptide</strong> presents in<strong> both the central and peripheral nervous systems</strong>&mdash;to the <strong>NK1 receptors. Substance P</strong> is significantly involved in the <strong>initiation of nausea and vomiting.</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. RANK ligand inhibitor:</span></strong><span style=\"font-size:12.0pt\"><strong> Incorrect</strong> because <strong>RANK ligand inhibitors </strong>like <strong>denosumab </strong>are used to <strong>treat osteoporosis</strong> and <strong>bone</strong> <strong>metastases</strong>, not nausea and vomiting. These drugs<strong> inhibit RANK ligand,</strong> a protein essential for the<strong> formation and survival of</strong> <strong>osteoclasts,</strong> which are involved in<strong> bone resorption.</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. NMDA antagonist:</span></strong><span style=\"font-size:12.0pt\"><strong> Incorrect</strong> as <strong>NMDA antagonists,</strong> such as<strong> memantine</strong>, <strong>target cognitive </strong>decline in <strong>Alzheimer&rsquo;s disease</strong> rather than <strong>nausea and vomiting.</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. 5 HT3 antagonist:</span></strong><span style=\"font-size:12.0pt\"> <strong>Incorrect</strong> because<strong> 5-HT3 antagonists, </strong>like<strong> ondansetron and granisetron</strong>, also<strong> prevent nausea and</strong> <strong>vomiting </strong>in settings like<strong> chemotherapy and post-operation </strong>but function by<strong> blocking 5-HT3 receptors</strong> on the <strong>vagus nerve</strong> and in the <strong>central nervous system</strong>, <strong>not<strong> </strong>NK1 receptors.</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational Objective:</span></u></strong></span></span><br />\r\n&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><strong>NK1 receptor antagonist </strong>used primarily to <strong>prevent delayed chemotherapy-induced nausea and vomiting</strong> by<strong> inhibiting </strong>the action of <strong>substance P on NK1 receptors.</strong></span></span></span></p>",
      "correct_choice_id": 33065,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 12739,
      "choices": [
        {
          "id": 50918,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Piperacillin-Tazobactam</span></span></span></p>"
        },
        {
          "id": 50919,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Cefoperazone</span></span></span></p>"
        },
        {
          "id": 50920,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Imipenem-cilstatin</span></span></span></p>"
        },
        {
          "id": 50921,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Vancomycin</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">All the following drugs are effective against Pseudomonas aeruginosa EXCEPT.</span></span></span></p>",
      "unique_key": "Q2878260",
      "question_audio": null,
      "question_video": null,
      "map_id": 36298,
      "difficulty_level": "beginner",
      "subjects_id": [
        4
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. D. Vancomycin</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Vancomycin </strong>is an antibiotic that is<strong> not effective against Pseudomonas aeruginosa, </strong>which is a <strong>Gram-negative bacterium.</strong> <strong>Vancomycin&#39;s mechanism</strong> of action is primarily<strong> against Gram-positive bacteria by inhibiting cell wall synthesis, </strong>and it <strong>does not</strong> <strong>penetrate the outer membrane of Gram-negative bacteria </strong>like Pseudomonas, rendering it<strong> ineffective against such organisms</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option&nbsp;</span></strong><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">A.&nbsp;</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Incorrect </strong>because <strong>Piperacillin-Tazobactam is a penicillin antibiotic</strong> combined with a <strong>beta-lactamase inhibitor, effective</strong> <strong>against Pseudomonas aeruginosa.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option&nbsp;</span></strong><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">B.&nbsp;</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Incorrect </strong>because<strong> Cefoperazone is a third-generation cephalosporin </strong>with <strong>activity against Pseudomonas aeruginosa.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option&nbsp;</span></strong><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">C.&nbsp;</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Incorrect </strong>because <strong>Imipenem-cilastatin </strong>is a <strong>carbapenem antibiotic </strong>that is <strong>effective against a broad spectrum of bacteria</strong>, including <strong>Pseudomonas aeruginosa</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Anti-Pseudomonal Drugs</span></span></strong></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/06/picture22.jpg\" style=\"height:457px; width:1000px\" /><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/06/picture23.jpg\" style=\"height:320px; width:1000px\" /></span></span></strong></p>",
      "correct_choice_id": 50921,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 8279,
      "choices": [
        {
          "id": 33083,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Community acquired pneumonia</span></span></span></p>"
        },
        {
          "id": 33084,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Clostridium difficile infection</span></span></span></p>"
        },
        {
          "id": 33085,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Osteoporosis</span></span></span></p>"
        },
        {
          "id": 33086,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Hypothyroidism</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">All of the following adverse effects are associated with the use of proton pump inhibitors except?</span></span></p>",
      "unique_key": "Q3937347",
      "question_audio": null,
      "question_video": null,
      "map_id": 36302,
      "difficulty_level": "intermediate",
      "subjects_id": [
        4
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. D) Hypothyroidism</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><strong>Proton pump inhibitors (PPIs) </strong>are commonly associated with <strong>several adverse effects</strong> due to their <strong>mechanism of reducing gastric acid secretion,</strong> but <strong>hypothyroidism </strong>is<strong> not</strong> one of them. The <strong>absence of </strong>any known link between <strong>PPI use </strong>and the development or exacerbation of <strong>thyroid function</strong> makes <strong>option D the correct answer </strong>as it is not an associated adverse effect.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Community acquired pneumonia:</span></strong><span style=\"font-size:12.0pt\"> Correctly associated with<strong> PPIs.</strong> Some studies have indicated an<strong> increased risk of</strong> <strong>pneumonia, </strong>particularly in vulnerable groups such as the<strong> elderly </strong>or those with <strong>existing respiratory conditions</strong>, possibly due to <strong>alterations in stomach pH </strong>affecting<strong> gut and respiratory flora.</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Clostridium difficile infection:</span></strong><span style=\"font-size:12.0pt\"> <strong>Correctly </strong>associated with<strong> PPIs. </strong>The<strong> reduction in gastric acidity</strong> can lead to an environment <strong>more conducive</strong> to the <strong>growth of Clostridium difficile</strong>, potentially resulting in <strong>severe and life-threatening infections.</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Osteoporosis:</span></strong><span style=\"font-size:12.0pt\"> <strong>Correctly </strong>associated with<strong> PPIs</strong>. <strong>Chronic</strong> use of <strong>PPIs</strong> may<strong> impact calcium absorption</strong> and <strong>bone metabolism,</strong> leading to an<strong> increased risk of osteoporosis </strong>and related<strong> fractures,</strong> especially in populations at <strong>risk like postmenopausal women</strong> and the<strong> elderly.</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">While <strong>PPIs are linked </strong>to several significant <strong>adverse effects</strong> such as <strong>increased risks of community-acquired pneumonia,</strong> <strong>Clostridium</strong> <strong>difficile infections</strong>, and<strong> osteoporosis</strong>, they are<strong> not </strong>associated with <strong>causing or worsening hypothyroidism.</strong></span></span></span></p>",
      "correct_choice_id": 33086,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 8282,
      "choices": [
        {
          "id": 33095,
          "text": "<p><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Omeprazole</span></span></p>"
        },
        {
          "id": 33096,
          "text": "<p><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Lansoprazole</span></span></p>"
        },
        {
          "id": 33097,
          "text": "<p><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Esomeprazole</span></span></p>"
        },
        {
          "id": 33098,
          "text": "<p><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Rabeprazole</span></span></p>"
        }
      ],
      "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following drugs have least affinity for CYP3A4?</span></span></p>",
      "unique_key": "Q3429833",
      "question_audio": null,
      "question_video": null,
      "map_id": 36303,
      "difficulty_level": "intermediate",
      "subjects_id": [
        4
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. D) Rabeprazole</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><strong>Rabeprazole</strong> has the<strong> least affinity</strong> for the <strong>cytochrome P450 enzyme CYP3A4 compared </strong>to the other listed <strong>proton pump inhibitors</strong> <strong>(PPIs)</strong>. It is primarily<strong> metabolized via CYP2C19,</strong> with <strong>minimal metabolism </strong>occurring through <strong>CYP3A4.</strong> This <strong>lower affinity</strong><strong> </strong>for<strong> CYP3A4</strong> <strong>reduces</strong> the potential for<strong> drug interactions </strong>that are common with<strong> other PPIs </strong>that are <strong>metabolized</strong> <strong>more extensively </strong>by this<strong> enzyme</strong>.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Omeprazole:</span></strong><span style=\"font-size:12.0pt\"> <strong>Incorrect </strong>because<strong> Omeprazole</strong> is<strong> extensively metabolized by CYP3A4, </strong>making it <strong>more likely </strong>to <strong>interact</strong> with <strong>other drugs</strong> metabolized by this enzyme.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Lansoprazole:</span></strong><span style=\"font-size:12.0pt\"> <strong>Incorrect</strong> as <strong>Lansoprazole</strong> also has significant metabolism via <strong>CYP3A4, </strong>similar to <strong>omeprazole,</strong> which <strong>increases its potential</strong> for<strong> drug interactions.</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Esomeprazole:</span></strong><span style=\"font-size:12.0pt\"><strong> Incorrect</strong> because <strong>Esomeprazole,</strong> the<strong> S-isomer of omeprazole,</strong> is extensively<strong> metabolized by CYP3A4</strong>, thus having a<strong> higher affinity for this enzyme</strong> compared to<strong> rabeprazole.</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><strong>Rabeprazole</strong> has the<strong> least affinity</strong> for the enzyme<strong> CYP3A4</strong> among the<strong> listed PPIs</strong>, potentially leading to<strong> fewer drug interactions</strong> related to<strong> metabolism</strong> by<strong> this pathway.</strong></span></span></span></p>",
      "correct_choice_id": 33098,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 8287,
      "choices": [
        {
          "id": 33115,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\">Domperidone</span></span></span></p>"
        },
        {
          "id": 33116,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\">Metoclopramide </span></span></span></p>"
        },
        {
          "id": 33117,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\">Cisapride</span></span></span></p>"
        },
        {
          "id": 33118,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Omeprazole</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Drug implicated in prolonging QT interval is? </span></span></p>",
      "unique_key": "Q5167100",
      "question_audio": null,
      "question_video": null,
      "map_id": 36305,
      "difficulty_level": "beginner",
      "subjects_id": [
        4
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. C) Cisapride</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C:</span></strong></span></span></p>\r\n\r\n<p><br />\r\n<span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><strong>Cisapride</strong> is a <strong>prokinetic agent</strong> that functions as a<strong> 5HT4 agonist, </strong>enhancing <strong>gastrointestinal motility</strong>. However, at<strong> high plasma</strong> <strong>concentrations</strong>, <strong>Cisapride</strong> has the<strong> potential to block cardiac potassium channels</strong>, which can<strong> lead to serious cardiac arrhythmias,</strong> such as <strong>polymorphic ventricular tachycardia </strong>(<strong>torsades de pointes</strong>). This<strong> arrhythmia</strong> is often preceded by<strong> QT interval prolongation on</strong> an<strong> electrocardiogram (ECG).</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Due to this risk,<strong> Cisapride</strong> usage is<strong> heavily restricted </strong>and<strong> contraindicated </strong>with drugs that <strong>inhibit microsomal enzymes</strong> (e.g., <strong>erythromycin and ketoconazole</strong>) which can <strong>increase its concentration.</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Domperidone:</span></strong><span style=\"font-size:12.0pt\"><strong> Incorrect</strong> because while <strong>Domperidone </strong>does have some <strong>cardiac risk</strong>, it is more specifically associated with an<strong> increased risk of serious ventricular arrhythmias</strong> and<strong> sudden cardiac death</strong> rather than QT prolongation.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Metoclopramide:</span></strong><span style=\"font-size:12.0pt\"> <strong>Incorrect </strong>as Metoclopramide, another<strong> prokinetic agent, </strong>primarily affects <strong>dopamine receptors</strong> and has <strong>not </strong>been commonly associated with<strong> QT prolongation.</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Omeprazole:</span></strong><span style=\"font-size:12.0pt\"><strong> Incorrect </strong>because Omeprazole, a <strong>proton pump inhibitor,</strong> <strong>does not</strong> typically cause <strong>QT prolongation</strong> as part of its side effect profile.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><strong>Cisapride </strong>is associated with<strong> QT interval prolongation </strong>and can lead to <strong>torsades de pointes</strong>, particularly at<strong> high concentrations</strong> or when<strong> combined with other drugs</strong> that <strong>inhibit its metabolism.</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Important drugs causing QT prolongation </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/03/screenshot-2024-05-03-095836.png\" style=\"height:433px; width:1000px\" /></span></strong></span></span></p>",
      "correct_choice_id": 33117,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 8288,
      "choices": [
        {
          "id": 33119,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Opioids delay passage of gut contents by reducing peristalsis</span></span></span></p>"
        },
        {
          "id": 33120,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Loperamide is an opioid with anti-motility action</span></span></span></p>"
        },
        {
          "id": 33121,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Anti-motility drugs are best drugs for infective diarrhea</span></span></span></p>"
        },
        {
          "id": 33122,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Diphenoxylate overdose can cause respiratory depression</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">All the following statements about treatment of diarrhea are correct except? </span></span></p>",
      "unique_key": "Q4702821",
      "question_audio": null,
      "question_video": null,
      "map_id": 36306,
      "difficulty_level": "beginner",
      "subjects_id": [
        4
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. C) Anti-motility drugs are best drugs for infective diarrhea</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><strong>Anti-motility </strong>drugs such as<strong> loperamide and diphenoxylate </strong>are effective in<strong> reducing the symptoms of diarrhea </strong>by <strong>slowing peristalsis</strong> and <strong>allowing for greater absorption of water and electrolytes.</strong> However, they are<strong> not </strong>considered the best treatment option for <strong>infective diarrhea</strong>. Using <strong>anti-motility agents</strong> in infections can trap pathogens in the<strong> intestines</strong>, potentially <strong>prolonging the infection</strong> or <strong>exacerbating symptoms. </strong>Therefore, they are generally<strong> avoided</strong> in cases of <strong>diarrhea</strong> suspected to be <strong>due to a bacterial or viral</strong> <strong>infection.</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Opioids delay passage of gut contents by reducing peristalsis:</span></strong><span style=\"font-size:12.0pt\"><strong> Correct</strong>, opioids<strong> inhibit gastrointestinal motility,</strong> leading to <strong>slower transit </strong>times and<strong> more water absorption</strong>, which can help<strong> alleviate diarrhea symptoms.</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Loperamide is an opioid with anti-motility action:</span></strong><span style=\"font-size:12.0pt\"> <strong>Correct</strong>, <strong>loperamide</strong> acts on <strong>opioid receptors</strong> in the <strong>gastrointestinal</strong> <strong>tract</strong> to <strong>reduce motility</strong> and<strong> increase the absorption of fluids, </strong>making it effective in managing diarrhea.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Diphenoxylate overdose can cause respiratory depression:</span></strong><span style=\"font-size:12.0pt\"><strong> Correct,</strong> <strong>diphenoxylate</strong> is an <strong>opioid </strong>and, like other opioids, can cause significant<strong> respiratory depression</strong> if <strong>overdosed.</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">While<strong> anti-motility drugs </strong>are <strong>effective</strong> in managing<strong> non-infective diarrhea,</strong> they are <strong>not </strong>recommended for<strong> treating infective diarrhea</strong> due to the <strong>risk</strong> of prolonging the<strong> presence of pathogens</strong> in the <strong>gastrointestinal tract.</strong></span></span></span></p>",
      "correct_choice_id": 33121,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 8289,
      "choices": [
        {
          "id": 33123,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">It is a pro-drug that is converted to peripherally acting enkephalinase inhibitor</span></span></span></p>"
        },
        {
          "id": 33124,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">It is a drug used in treatment of constipation</span></span></span></p>"
        },
        {
          "id": 33125,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">It is metabolized by liver</span></span></span></p>"
        },
        {
          "id": 33126,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">It has anti- secretory action in GIT</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">False statement about racecadotril is?</span></span></p>",
      "unique_key": "Q9859887",
      "question_audio": null,
      "question_video": null,
      "map_id": 36307,
      "difficulty_level": "intermediate",
      "subjects_id": [
        4
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. B) It is drug used in constipation</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B:</span></strong></span></span></p>\r\n\r\n<p><br />\r\n<span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><strong>Racecadotril </strong>is an <strong>antidiarrheal medication</strong> that works by<strong> inhibiting enkephalinase</strong>, which<strong> increases levels of endogenous</strong> <strong>opioids</strong> in the <strong>gut,</strong> thereby <strong>reducing secretion of water and electrolytes </strong>and <strong>decreasing stool output.</strong> It is used specifically for treating <strong>acute</strong> <strong>diarrhea, not constipation</strong>. Using <strong>racecadotril for constipation </strong>would be<strong> inappropriate</strong> as it would exacerbate the condition by further<strong> reducing intestinal motility</strong> and <strong>fluid secretion.</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. It is a pro-drug that is converted to peripherally acting enkephalinase inhibitor:</span></strong><span style=\"font-size:12.0pt\"> <strong>Correct</strong>, <strong>racecadotril</strong> is a<strong> pro-drug </strong>that is <strong>metabolized into thiorphan</strong>, which acts<strong> peripherally </strong>to<strong> inhibit enkephalinase</strong>, thus <strong>prolonging the action</strong> of <strong>naturally occurring</strong> <strong>opioids</strong> that <strong>decrease gut motility.</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. It is metabolized by liver:</span></strong><span style=\"font-size:12.0pt\"><strong> Correct, racecadotril </strong>undergoes <strong>metabolic</strong> processes in the<strong> liver, </strong>converting it into <strong>its active</strong> <strong>form.</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. It has anti-secretory action in GIT:</span></strong><span style=\"font-size:12.0pt\"> <strong>Correct,</strong> by <strong>inhibiting the breakdown of enkephalins,</strong> <strong>racecadotril </strong>enhances their <strong>natural</strong> <strong>anti-secretory effects in the gastrointestinal tract,</strong> which is<strong> beneficial</strong> in <strong>treating diarrhea.</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><strong>Racecadotril </strong>is<strong> indicated</strong> for the treatment of <strong>acute diarrhea</strong> and works by<strong> reducing gastrointestinal secretion;</strong> it is <strong>not</strong> used for <strong>constipation</strong> and<strong> indeed</strong> would be <strong>contraindicated</strong> in such cases.</span></span></span></p>",
      "correct_choice_id": 33124,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 8290,
      "choices": [
        {
          "id": 33127,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Chronic diarrhea</span></span></span></p>"
        },
        {
          "id": 33128,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Acute secretory diarrhea</span></span></span></p>"
        },
        {
          "id": 33129,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Chronic constipation</span></span></span></p>"
        },
        {
          "id": 33130,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Diabetic gastroparesis</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Racecadotril is used for?</span></span></p>",
      "unique_key": "Q2817742",
      "question_audio": null,
      "question_video": null,
      "map_id": 36308,
      "difficulty_level": "beginner",
      "subjects_id": [
        4
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. B) Acute secretory diarrhea </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><strong>Racecadotril </strong>is an<strong> effective</strong> treatment specifically for <strong>acute secretory diarrhea.</strong> It operates as a <strong>peripherally acting enkephalinase</strong> <strong>inhibitor,</strong> which <strong>helps</strong> to maintain <strong>higher levels of endogenous enkephalins</strong>. These<strong> enkephalins reduce chloride secretion</strong> into the <strong>intestines </strong>and simultaneously<strong> increase the absorption of sodium and water. </strong>This dual action significantly <strong>reduces both the volume</strong> and<strong> frequency of diarrhea without </strong>directly affecting the <strong>motility of the gastrointestinal tract.</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Chronic diarrhea:</span></strong><span style=\"font-size:12.0pt\"> <strong>Incorrect </strong>because<strong> Racecadotril </strong>is<strong> not</strong> used for <strong>chronic diarrhea </strong>conditions as its effects are more suited to <strong>acute cases.</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Chronic constipation:</span></strong><span style=\"font-size:12.0pt\"> <strong>Incorrect </strong>as <strong>Racecadotril&#39;s</strong> mechanism of <strong>reducing fluid secretion</strong> would be<strong> detrimental in</strong> <strong>constipation</strong>, potentially <strong>worsening the condition.</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Diabetic gastroparesis:</span></strong><span style=\"font-size:12.0pt\"><strong> Incorrect</strong> because <strong>Racecadotril</strong> <strong>does not </strong>affect<strong> gastric emptying or motility</strong>, which are the primary concerns in <strong>diabetic gastroparesis.</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><strong>Racecadotril </strong>is specifically <strong>used for acute secretory diarrhea</strong> due to its<strong> ability to reduce fluid secretion</strong> in the <strong>gut</strong>, thereby <strong>decreasing stool output</strong> <strong>without</strong> significantly affecting <strong>intestinal motility.</strong></span></span></span></p>",
      "correct_choice_id": 33128,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 8292,
      "choices": [
        {
          "id": 33135,
          "text": "<p><span style=\"font-size:12.0pt;\">5-HT3 antagonist</span></p>"
        },
        {
          "id": 33136,
          "text": "<p><span style=\"font-size:12.0pt;\">D2-antagonist</span></p>"
        },
        {
          "id": 33137,
          "text": "<p><span style=\"font-size:12.0pt;\">5-HT4 agonist</span></p>"
        },
        {
          "id": 33138,
          "text": "<p><span style=\"font-size:12.0pt;\">M3-antagonist</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Most important mechanism of action for antiemetic property of metoclopramide is?</span></p>",
      "unique_key": "Q2853076",
      "question_audio": null,
      "question_video": null,
      "map_id": 36309,
      "difficulty_level": "beginner",
      "subjects_id": [
        4
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) D2-antagonist</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B:</strong></span></p><p><br><span style=\"font-size:12.0pt;\"><strong>Metoclopramide's antiemetic effect primarily results from its property as a D2 (dopamine) receptor antagonist. By blocking D2 receptors in the chemoreceptor trigger zone of the central nervous system, metoclopramide prevents dopamine from binding to these receptors, which is a crucial step in preventing nausea and vomiting. This action effectively suppresses the vomiting reflex, which is particularly useful in treating nausea and vomiting caused by gastroesophageal reflux and delayed stomach emptying.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong><u>Explanation:</u></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. 5-HT3 antagonist: Incorrect because while 5-HT3 antagonists are indeed used as antiemetics, metoclopramide does not act through this mechanism. Drugs like ondansetron are typical examples of 5-HT3 antagonists.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. 5-HT4 agonist: Incorrect </strong>as <strong>metoclopramide </strong>does have some <strong>agonistic action at 5-HT4 receptors </strong>which <strong>promotes</strong> <strong>gastric</strong> <strong>emptying,</strong> but this is <strong>not</strong> the primary mechanism responsible for its <strong>antiemetic effects.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. M3-antagonist: Incorrect</strong> because<strong> metoclopramide does not </strong>function as an<strong> M3 muscarinic antagonist</strong>.<strong> Antimuscarinics</strong> like<strong> scopolamine </strong>work by this<strong> mechanism</strong> for their<strong> antiemetic effects, </strong>which is different from how <strong>metoclopramide operates.</strong></span></p><p><span style=\"font-size:11pt;\">&nbsp;</span></p><p><span style=\"font-size:12.0pt;\"><strong><u>Educational Objective</u></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Anti-emetics</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/03/screenshot-2024-05-03-104212.png\" alt=\"\" width=\"1000\" height=\"636\"></strong></span></p>",
      "correct_choice_id": 33136,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 8293,
      "choices": [
        {
          "id": 33139,
          "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Diphenhydramine one hour before the trip </span></span></p>"
        },
        {
          "id": 33140,
          "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Scopolamine patch one night before the trip</span></span></p>"
        },
        {
          "id": 33141,
          "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ranitidine one night and one hour before the trip</span></span></p>"
        },
        {
          "id": 33142,
          "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Pantoprazole-one hour before the trip</span></span></p>"
        }
      ],
      "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">You are going on a trip to a hill station with a friend who developed nausea and vomiting while travelling in the hills previously. Which of the following measure can be taken to prevent such an episode this time? </span></span></p>",
      "unique_key": "Q7749736",
      "question_audio": null,
      "question_video": null,
      "map_id": 36310,
      "difficulty_level": "beginner",
      "subjects_id": [
        4
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. B) Scopolamine patch one night before the trip</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B:</span></strong></span></span></p>\r\n\r\n<p><br />\r\n<span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><strong>Scopolamine,</strong> a <strong>muscarinic receptor antagonist</strong>, is particularly effective in <strong>preventing motion sickness,</strong> which can lead to <strong>nausea and</strong> <strong>vomiting during travel.</strong> The <strong>scopolamine patch s</strong>hould be applied<strong> behind the ear</strong> at <strong>least 12 hours before travel begins.</strong> This<strong> timing</strong> allows the <strong>drug to be absorbed </strong>and <strong>start working </strong>by the <strong>time the trip starts</strong>, and it provides <strong>protection for up to 3 days,</strong> making it an<strong> ideal choice </strong>for preventing <strong>motion sickness </strong>during <strong>hill station travels.</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Diphenhydramine one hour before the trip:</span></strong><span style=\"font-size:12.0pt\"><strong> Incorrect </strong>as<strong> diphenhydramine,</strong> while also <strong>used to treat motion sickness </strong>due to its <strong>antihistaminic properties,</strong> is generally considered<strong> less effective</strong> than scopolamine. It also has<strong> sedative effects</strong>, which can be <strong>undesirable </strong>for<strong> some travelers.</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Ranitidine one night and one hour before the trip:</span></strong><span style=\"font-size:12.0pt\"><strong> Incorrect</strong> because Ranitidine is an <strong>H2 receptor antagonist </strong>primarily used for<strong> reducing gastric acid </strong>and <strong>does not</strong> have<strong> antiemetic </strong>properties effective against<strong> motion sickness.</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Pantoprazole one hour before the trip:</span></strong><span style=\"font-size:12.0pt\"> <strong>Incorrect </strong>as <strong>Pantoprazole</strong>, a<strong> proton pump inhibitor,</strong> <strong>reduces</strong> stomach acid production but<strong> does not</strong> prevent<strong> nausea and vomiting</strong> due to <strong>motion sickness.</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p><br />\r\n<span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><strong>Scopolamine patch</strong> is a<strong> very effective</strong> preventive measure <strong>against motion sickness</strong> due to its <strong>muscarinic antagonist properties</strong> and should be applied<strong> 12 hours before travel </strong>to ensure<strong> efficacy.</strong></span></span></span></p>",
      "correct_choice_id": 33140,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 8294,
      "choices": [
        {
          "id": 33143,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Buy ORS and give after preparing according to instructions.</span></span></span></p>"
        },
        {
          "id": 33144,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">ORS and antibiotics, both tinidazole and ofloxacin.</span></span></span></p>"
        },
        {
          "id": 33145,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Give only ofloxacin because tinidazole is not required as Giardia will not cause diarrhea within 4 hours.</span></span></span></p>"
        },
        {
          "id": 33146,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Go to a hospital as he needs to be shown immediately, as night is approaching.</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">On a trip, 4 hours after having lunch at a restaurant, your friend develops diarrhea, and had 5 loose stools. There are signs of minimal dehydration. What should be your management? </span></span></p>",
      "unique_key": "Q9591751",
      "question_audio": null,
      "question_video": null,
      "map_id": 36311,
      "difficulty_level": "beginner",
      "subjects_id": [
        4
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. A) Buy ORS and give after preparing according to instructions</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The primary and most effective treatment for <strong>acute diarrhea </strong>with <strong>minimal dehydration </strong>is<strong> oral rehydration therapy (ORT)</strong>. ORS helps <strong>replace lost fluids and electrolytes </strong>due to diarrhea and is vital in <strong>preventing dehydration from worsening. </strong>It is crucial to prepare the <strong>ORS </strong>according to<strong> package instructions</strong> to ensure the <strong>correct balance of salts and glucose. </strong>This simple intervention is typically sufficient in managing cases of<strong> acute diarrhea </strong>where<strong> no severe symptoms </strong>or <strong>complications </strong>(like <strong>high fever, bloody stools, or severe</strong> <strong>dehydration</strong>) are <strong>present.</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. ORS and antibiotics, both tinidazole and ofloxacin:</span></strong><span style=\"font-size:12.0pt\"><strong> Incorrect</strong> because <strong>antibiotics</strong> are<strong> not </strong>recommended <strong>without </strong>a <strong>specific</strong> <strong>diagnosis</strong> that <strong>indicates a bacterial infection, </strong>and their<strong> unnecessary use</strong> can lead to <strong>resistance and other complications.</strong> Furthermore, <strong>antibiotics </strong>are<strong> not effective against viruses</strong> or <strong>non-bacterial agents </strong>that might cause<strong> diarrhea.</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Give only ofloxacin because tinidazole is not required as Giardia will not cause diarrhea within 4 hours:</span></strong><span style=\"font-size:12.0pt\"> <strong>Incorrect</strong> as this assumes a<strong> specific diagnosis without evidence</strong>, and the<strong> use of antibiotics</strong> like<strong> ofloxacin </strong>should be <strong>guided by a medical professional following appropriate tests.</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Go to a hospital as he needs to be shown immediately, as night is approaching:</span></strong><span style=\"font-size:12.0pt\"> <strong>Not </strong>necessary at this stage as the <strong>symptoms are mild and manageable with ORS.</strong> <strong>Hospital visits </strong>are advised if <strong>symptoms escalate </strong>or if there are signs of severe <strong>dehydration or other complications</strong>.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><strong>ORS</strong> is the<strong> first line of management for mild cases of diarrhea</strong> with<strong> minimal dehydration</strong>. It&#39;s <strong>effective, safe,</strong> and<strong> does not</strong> contribute to <strong>antibiotic resistance.</strong></span></span></span></p>",
      "correct_choice_id": 33143,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 8295,
      "choices": [
        {
          "id": 33147,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Lubiprostine</span></span></span></p>"
        },
        {
          "id": 33148,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Linaclotide</span></span></span></p>"
        },
        {
          "id": 33149,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Tegaserod</span></span></span></p>"
        },
        {
          "id": 33150,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Methyl naltrexone</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Which of the following is a Guanylate Cyclase C agonist used in irritable bowel syndrome? </span></span></span></p>",
      "unique_key": "Q3568960",
      "question_audio": null,
      "question_video": null,
      "map_id": 36312,
      "difficulty_level": "intermediate",
      "subjects_id": [
        4
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. B) Linaclotide</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><strong>Linaclotide</strong> is a<strong> guanylate cyclase-C agonist </strong>specifically <strong>used</strong> for the treatment of <strong>irritable bowel syndrome with constipation (IBS-C)</strong> and <strong>chronic idiopathic constipation (CIC). </strong>Its mechanism involves <strong>increasing the secretion of chloride and bicarbonate </strong>into the <strong>intestinal lumen.</strong> This action <strong>leads to an increase in fluid in the gut</strong>, which <strong>softens stools </strong>and <strong>enhances bowel movements.</strong> <strong>Linaclotide&#39;s</strong> unique<strong> mode of action</strong> focuses on<strong> improving the overall function</strong> of the <strong>bowel </strong>rather than merely <strong>treating symptoms.</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Lubiprostone:</span></strong><span style=\"font-size:12.0pt\"><strong> Incorrect</strong> because<strong> Lubiprostone</strong> works by <strong>activating chloride channels</strong> rather than <strong>acting as a guanylate</strong> <strong>Cyclase-C agonist. </strong>It is<strong> used</strong> primarily for <strong>treating chronic idiopathic constipation</strong> and <strong>IBS-C</strong> but via a different mechanism.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Tegaserod:</span></strong><span style=\"font-size:12.0pt\"> <strong>Incorrect</strong> as Tegaserod is a <strong>5-HT4 receptor agonist, not </strong>a <strong>guanylate Cyclase-C agonist.</strong> It&rsquo;s<strong> used </strong>to treat<strong> IBS-C</strong> in women by <strong>enhancing peristaltic reflex and bowel motility.</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Methyl naltrexone:</span></strong><span style=\"font-size:12.0pt\"> <strong>Incorrect</strong> because <strong>Methyl naltrexone</strong> is a <strong>peripheral opioid receptor antagonist </strong>used specifically for <strong>opioid-induced constipation</strong>, acting by <strong>blocking the effects of opioids</strong> in the gut<strong> without </strong>affecting the <strong>central nervous system.</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/03/screenshot-2024-05-03-105608.png\" style=\"height:528px; width:1000px\" /></span></u></strong></span></span></p>",
      "correct_choice_id": 33148,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 8296,
      "choices": [
        {
          "id": 33151,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Chloride channel activator</span></span></span></p>"
        },
        {
          "id": 33152,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Chloride channel inhibitor</span></span></span></p>"
        },
        {
          "id": 33153,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Sodium channel activator</span></span></span></p>"
        },
        {
          "id": 33154,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Sodium channel inhibitor</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Lubiprostone is a?</span></span></p>",
      "unique_key": "Q2034861",
      "question_audio": null,
      "question_video": null,
      "map_id": 36313,
      "difficulty_level": "beginner",
      "subjects_id": [
        4
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. A) Chloride channel activator</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><strong>Lubiprostone </strong>is a <strong>bicyclic fatty acid metabolite </strong>and<strong> analogue of prostaglandin E1, </strong>which specifically <strong>activates type-2 chloride</strong> <strong>channels (ClC-2)</strong> in the<strong> lining of the small intestine.</strong> This action leads to <strong>the secretion of chloride-rich fluids into the gut,</strong> which in turn <strong>enhances the movement of stool </strong>through the<strong> bowel</strong> by increasing intestinal fluid secretion and <strong>softening the stool.</strong> This mechanism is<strong> particularly effective </strong>in<strong> treating chronic constipation</strong> and <strong>irritable bowel syndrome with constipation (IBS-C)</strong> in adult women by<strong> promoting more regular bowel movements</strong> and<strong> improving stool consistency.</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Chloride channel inhibitor:</span></strong><span style=\"font-size:12.0pt\"> <strong>Incorrect</strong> as <strong>Lubiprostone</strong> does the <strong>opposite by activating,</strong> <strong>not inhibiting,</strong> <strong>chloride channels.</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Sodium channel activator:</span></strong><span style=\"font-size:12.0pt\"><strong> Incorrect</strong> because<strong> Lubiprostone does not</strong> affect <strong>sodium channels</strong>; its action is <strong>specific to</strong> <strong>chloride channels.</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Sodium channel inhibitor:</span></strong><span style=\"font-size:12.0pt\"><strong> Incorrect </strong>as <strong>Lubiprostone</strong> has<strong> no activity </strong>on <strong>sodium channels</strong>, <strong>either as an activator or</strong> <strong>inhibitor.</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/03/screenshot-2024-05-03-110054.png\" style=\"height:375px; width:1000px\" /></span></u></strong></span></span></p>",
      "correct_choice_id": 33151,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 8297,
      "choices": [
        {
          "id": 33155,
          "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Atrial natriuretic peptide</span></span></p>"
        },
        {
          "id": 33156,
          "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Aprepitant</span></span></p>"
        },
        {
          "id": 33157,
          "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Bradykinin</span></span></p>"
        },
        {
          "id": 33158,
          "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Enalapril</span></span></p>"
        }
      ],
      "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following is an antagonist of a peptide and is used to reduce chemotherapy induced nausea and vomiting?</span></span></p>",
      "unique_key": "Q5452149",
      "question_audio": null,
      "question_video": null,
      "map_id": 36314,
      "difficulty_level": "beginner",
      "subjects_id": [
        4
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. B) Aprepitant</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B:</span></strong></span></span></p>\r\n\r\n<p><br />\r\n<span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><strong>Aprepitant</strong> is a <strong>selective antagonist</strong> of the <strong>neurokinin-1 (NK1) receptor</strong>, which <strong>binds to substance P, </strong>a <strong>neuropeptide </strong>involved in <strong>vomiting</strong>. By <strong>blocking this receptor</strong>, aprepitant effectively<strong> reduces the incidence </strong>and <strong>severity of chemotherapy-induced nausea</strong> and <strong>vomiting, particularly </strong>the <strong>delayed phase </strong>that can occur a<strong> few days after treatment.</strong> This makes it an essential option in the management of<strong> nausea and vomiting </strong>associated with<strong> chemotherapy, </strong>often used as <strong>part of a combination</strong> therapy with other <strong>antiemetics to enhance efficacy.</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Atrial natriuretic peptide:</span></strong><span style=\"font-size:12.0pt\"><strong> </strong><strong>Incorrect </strong>as this <strong>peptide</strong> is involved in the<strong> regulation of blood pressure and fluid balance,</strong> <strong>not</strong> in the treatment of <strong>nausea or vomiting.</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Bradykinin:</span></strong><span style=\"font-size:12.0pt\"> <strong>Incorrect</strong> because<strong> Bradykinin is a peptide </strong>that plays a role in <strong>inflammation and blood pressure</strong> <strong>regulation</strong>, <strong>not</strong> directly in the <strong>control of nausea or vomiting.</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Enalapril:</span></strong><span style=\"font-size:12.0pt\"> <strong>Incorrect</strong> as <strong>Enalapril</strong> <strong>is </strong>an <strong>ACE inhibitor</strong> used primarily to treat <strong>high blood pressure</strong> and<strong> heart failure,</strong> and has <strong>no</strong> role in managing<strong> chemotherapy-induced nausea and vomiting.</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><strong>Aprepitant</strong> is an <strong>NK1 receptor antagonist</strong> used specifically to <strong>prevent chemotherapy-induced nausea and vomiting</strong> by <strong>blocking the</strong> <strong>action of substance P.</strong></span></span></span></p>",
      "correct_choice_id": 33156,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 8298,
      "choices": [
        {
          "id": 33159,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Lubiprostone</span></span></span></p>"
        },
        {
          "id": 33160,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Loperamide</span></span></span></p>"
        },
        {
          "id": 33161,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Alosetron</span></span></span></p>"
        },
        {
          "id": 33162,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Clonidine</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Drug used in irritable bowel syndrome with constipation is?</span></span></p>",
      "unique_key": "Q7579748",
      "question_audio": null,
      "question_video": null,
      "map_id": 36315,
      "difficulty_level": "beginner",
      "subjects_id": [
        4
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. A) Lubiprostone</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><strong>Lubiprostone </strong>is specifically indicated for the <strong>treatment of irritable bowel syndrome </strong>with <strong>constipation (IBS-C)</strong>. It functions as a <strong>chloride channel activator</strong>, <strong>increasing</strong> the secretion of <strong>chloride ions into the intestinal lumen</strong>, which in turn <strong>enhances fluid secretion</strong> and <strong>gastrointestinal motility</strong>. This mechanism helps <strong>alleviate constipation</strong> and the <strong>associated symptoms</strong> of<strong> IBS-C</strong> by <strong>facilitating easier stool passage</strong> and<strong> improving bowel function.</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Loperamide:</span></strong><span style=\"font-size:12.0pt\"> <strong>Incorrect </strong>because <strong>Loperamide</strong> is primarily an <strong>anti-diarrheal medication,</strong> used to <strong>treat irritable bowel</strong> <strong>syndrome with diarrhea (IBS-D) </strong>due to its action as a <strong>&micro;-opioid receptor agonist,</strong> which <strong>decreases intestinal motility.</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Alosetron:</span></strong><span style=\"font-size:12.0pt\"><strong> Incorrect</strong> as <strong>Alosetron is a 5-HT3 receptor antagonist</strong> used specifically for <strong>IBS</strong> with<strong> predominant diarrhea</strong> <strong>(IBS-D),</strong> where it helps by <strong>reducing visceral pain</strong> and <strong>slowing colonic transit.</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Clonidine:</span></strong><span style=\"font-size:12.0pt\"><strong> Incorrect</strong> because <strong>Clonidine </strong>is an <strong>alpha-2 agonist</strong> used mainly in the<strong> management of hypertension </strong>and <strong>not</strong> typically for<strong> BSI</strong>. It has some applications in <strong>diabetic diarrhea</strong>, but <strong>not </strong>in<strong> IBS with constipation.</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/03/screenshot-2024-05-03-111701.png\" style=\"height:430px; width:1000px\" /></span></u></strong></span></span></p>",
      "correct_choice_id": 33159,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 8299,
      "choices": [
        {
          "id": 33163,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Sorbitol </span></span></span></p>"
        },
        {
          "id": 33164,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Magnesium</span></span></span></p>"
        },
        {
          "id": 33165,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Polyethylene glycol</span></span></span></p>"
        },
        {
          "id": 33166,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Bisacodyl</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which is not an osmotic laxative?</span></span></p>",
      "unique_key": "Q3513898",
      "question_audio": null,
      "question_video": null,
      "map_id": 36316,
      "difficulty_level": "intermediate",
      "subjects_id": [
        4
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. D) Bisacodyl</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D:</span></strong></span></span></p>\r\n\r\n<p><br />\r\n<span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><strong>Bisacodyl</strong> is a<strong> stimulant laxative</strong>, <strong>not </strong>an <strong>osmotic laxative</strong>. It works by <strong>stimulating the intestinal mucosa </strong>and <strong>enhancing peristalsis,</strong> which <strong>facilitates bowel movements. </strong>This<strong> mechanism is distinct</strong> from that of <strong>osmotic laxatives</strong>, which function by <strong>drawing water </strong>into the <strong>bowel to soften stools</strong> and<strong> enhance bowel activity.</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Sorbitol:</span></strong><span style=\"font-size:12.0pt\"><strong> Incorrect</strong> as<strong> Sorbitol </strong>is an <strong>osmotic laxative</strong> that works by <strong>drawing water into the large intestine,</strong> <strong>increasing</strong> the <strong>water content in stools</strong>, which makes them <strong>easier to pass.</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Magnesium (e.g., magnesium citrate):</span></strong><span style=\"font-size:12.0pt\"> <strong>Incorrect</strong> because <strong>magnesium compounds </strong>are<strong> osmotic laxatives</strong>. They <strong>increase</strong> the <strong>amount of water in the intestines</strong>, primarily through <strong>osmosis, </strong>which <strong>softens the stool </strong>and<strong> naturally stimulates bowel movement.</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Polyethylene glycol:</span></strong><span style=\"font-size:12.0pt\"> <strong>Incorrect </strong>as it is an <strong>osmotic laxative</strong> known for its <strong>ability to retain water in the stool,</strong> which results in <strong>softer stools</strong> and <strong>promotes regular bowel movements.</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objectiv:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/03/screenshot-2024-05-03-112100.png\" style=\"height:580px; width:1000px\" /></span></u></strong></span></span></p>",
      "correct_choice_id": 33166,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 8300,
      "choices": [
        {
          "id": 33167,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Gastric ulcer</span></span></span></p>"
        },
        {
          "id": 33168,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Glaucoma</span></span></span></p>"
        },
        {
          "id": 33169,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Hypertension</span></span></span></p>"
        },
        {
          "id": 33170,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Congestive cardiac failure</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Pirenzepine is used for: </span></span></p>",
      "unique_key": "Q8169815",
      "question_audio": null,
      "question_video": null,
      "map_id": 36317,
      "difficulty_level": "beginner",
      "subjects_id": [
        4
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. A) Gastric ulcer</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A:</span></strong></span></span></p>\r\n\r\n<p><br />\r\n<span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><strong>Pirenzepine</strong> is a<strong> muscarinic receptor antagonist </strong>that primarily targets<strong> M1 receptors </strong>located in the<strong> gastric parietal cells</strong>. By <strong>blocking</strong> these<strong> receptors,</strong> pirenzepine effectively <strong>reduces gastric acid secretion</strong>. This action is particularly<strong> beneficial</strong> in the treatment of <strong>gastric</strong> <strong>and duodenal ulcers</strong>, where<strong> reducing stomach acid </strong>helps<strong> alleviate symptoms and promotes healing of the ulcerated tissues.</strong> <strong>Pirenzepine&#39;s selective</strong> <strong>inhibition </strong>of<strong> gastric acid production</strong> makes it an effective therapeutic agent for <strong>peptic ulcer disease.</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Glaucoma</span></strong><span style=\"font-size:12.0pt\"><strong>: Incorrect </strong>as <strong>Pirenzepine</strong> is<strong> not </strong>used to <strong>treat glaucoma.</strong> While<strong> muscarinic antagonists</strong> can affect <strong>eye conditions, pirenzepine&rsquo;s </strong>specific action on<strong> gastric secretions does not </strong>extend to<strong> intraocular pressure control.</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Hypertension:</span></strong><span style=\"font-size:12.0pt\"><strong> Incorrect</strong> because <strong>Pirenzepine does not </strong>play a role in the management of<strong> blood pressure.</strong> Its <strong>pharmacological effects</strong> are confined to the <strong>digestive system.</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Congestive cardiac failure:</span></strong><span style=\"font-size:12.0pt\"><strong> Incorrect </strong>as <strong>Pirenzepine</strong> is <strong>not </strong>indicated for <strong>heart conditions</strong> like<strong> congestive cardiac failure</strong>. Its <strong>primary mechanism of action does not</strong><strong> </strong>influence cardiac function or fluid management.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational Objective:</span></u></strong></span></span><br />\r\n&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><strong>Pirenzepine </strong>is utilized in the management of <strong>gastric and duodenal ulcers</strong> due to <strong>its ability to selectively block M1 muscarinic<strong> </strong>receptors</strong> in the stomach, <strong>reducing gastric acid secretion</strong> which is<strong> beneficial</strong> for<strong> </strong>treating <strong>peptic ulcers.</strong></span></span></span></p>",
      "correct_choice_id": 33167,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 8301,
      "choices": [
        {
          "id": 33171,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Granisetron</span></span></span></p>"
        },
        {
          "id": 33172,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Prazosin</span></span></span></p>"
        },
        {
          "id": 33173,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Clonidine</span></span></span></p>"
        },
        {
          "id": 33174,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Dimenhydrinate</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following is the drug of choice for treatment of chemotherapy-induced vomiting? </span></span></p>",
      "unique_key": "Q3280928",
      "question_audio": null,
      "question_video": null,
      "map_id": 36318,
      "difficulty_level": "beginner",
      "subjects_id": [
        4
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. A) Granisetron</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A:</span></strong></span></span></p>\r\n\r\n<p><br />\r\n<span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Granisetron is a 5-HT3 receptor antagonist that is highly effective in preventing both acute and delayed phases of chemotherapy-induced nausea and vomiting (CINV). It works by blocking serotonin receptors in the area postrema and the vagal nerve terminals, which are critical in the vomiting reflex pathway triggered by chemotherapy. This mechanism makes Granisetron particularly effective in managing CINV.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Prazosin:</span></strong><span style=\"font-size:12.0pt\"> Incorrect because Prazosin is an alpha-1 blocker used primarily for managing hypertension and benign prostatic hyperplasia, not for vomiting.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Clonidine:</span></strong><span style=\"font-size:12.0pt\"> Incorrect as Clonidine is an alpha-2 agonist, used mainly for hypertension, ADHD, and anxiety disorders, and does not have a primary role in controlling chemotherapy-induced vomiting.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Dimenhydrinate:</span></strong><span style=\"font-size:12.0pt\"> Incorrect because Dimenhydrinate, an antihistamine, is primarily used for motion sickness and vertigo. While it can treat nausea and vomiting, it is not the drug of choice for chemotherapy-induced vomiting.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Granisetron is the drug of choice for managing chemotherapy-induced vomiting due to its effective inhibition of 5-HT3 receptors, critical in blocking the emetic pathway triggered by chemotherapy </span></span></span></p>",
      "correct_choice_id": 33171,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 8302,
      "choices": [
        {
          "id": 33175,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">GLP-2 analog</span></span></span></p>"
        },
        {
          "id": 33176,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">5HT-1B/1D Agonist</span></span></span></p>"
        },
        {
          "id": 33177,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">GLP-1 analogs</span></span></span></p>"
        },
        {
          "id": 33178,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">C-peptide analogs</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">What is the mechanism of action of teduglutide in short bowel syndrome? </span></span></p>",
      "unique_key": "Q6174160",
      "question_audio": null,
      "question_video": null,
      "map_id": 36319,
      "difficulty_level": "difficult",
      "subjects_id": [
        4
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. A) GLP-2 analog</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Teduglutide is a glucagon-like peptide-2 (GLP-2) analog used in the treatment of short bowel syndrome. As a GLP-2 analog, teduglutide mimics the natural GLP-2 hormone which plays a significant role in the regeneration and repair of intestinal tissue. Its action stimulates intestinal growth and enhances the absorptive capacity of the remaining intestine. This is crucial in patients with short bowel syndrome, where substantial segments of the intestine may be missing or functionally compromised, leading to challenges in adequate nutrient absorption.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. 5HT-1B/1D Agonist:</span></strong><span style=\"font-size:12.0pt\"> Incorrect because 5HT-1B/1D agonists, such as triptans, are primarily used for migraine relief through vasoconstriction and inhibition of CGRP release, not for treating intestinal issues.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. GLP-1 analogs:</span></strong><span style=\"font-size:12.0pt\"> Incorrect as GLP-1 analogs like exenatide and liraglutide are used in diabetes management due to their effects on insulin secretion and appetite suppression, rather than intestinal growth or nutrient absorption.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. C-peptide analogs:</span></strong><span style=\"font-size:12.0pt\"> Incorrect because C-peptide analogs relate to insulin processing and are not used for treating conditions like short bowel syndrome.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Teduglutide acts as a GLP-2 analog, which is critical for promoting intestinal growth and enhancing the absorptive functions of the gut, making it effective in managing short bowel syndrome.</span></span></span></p>",
      "correct_choice_id": 33175,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 8303,
      "choices": [
        {
          "id": 33179,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Alosetron </span></span></span></p>"
        },
        {
          "id": 33180,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Clozapine </span></span></span></p>"
        },
        {
          "id": 33181,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Tegaserod</span></span></span></p>"
        },
        {
          "id": 33182,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Mosapride</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">A patient present with chronic diarrhea and is prescribed an anti-diarrheal medication. Which of the following drugs acts by inhibiting 5-HT and is used specifically for irritable bowel syndrome with diarrhea (IBS-D)? </span></span></span></p>",
      "unique_key": "Q9472342",
      "question_audio": null,
      "question_video": null,
      "map_id": 36320,
      "difficulty_level": "intermediate",
      "subjects_id": [
        4
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. A) Alosetron</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><strong>Alosetron</strong> is a<strong> 5-HT3 receptor antagonist</strong> used specifically for the management of<strong> irritable bowel syndrome with diarrhea (IBS-D),</strong> particularly in <strong>women</strong>. By <strong>blocking the 5-HT3 receptors</strong>, Alosetron <strong>slows colonic transit time</strong>, <strong>reduces visceral hypersensitivity,</strong> and <strong>improves the overall symptoms</strong> associated with<strong> IBS-D.</strong> This includes <strong>reductions in abdominal pain,</strong> <strong>stool frequency, consistency, and urgency,</strong> making it a<strong> targeted choice</strong> for this condition. It is particularly noted for its efficacy in <strong>improving abdominal discomfort</strong> <strong>and diarrhea </strong>but must be<strong> used cautiously </strong>due to potential serious<strong> side effects</strong> like <strong>ischemic colitis.</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Clozapine:</span></strong><span style=\"font-size:12.0pt\"><strong> Incorrect</strong> because Clozapine is an <strong>atypical antipsychotic </strong>primarily used for the treatment of <strong>schizophrenia and</strong> is<strong> not </strong>used for <strong>treating diarrhea or IBS.</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Tegaserod:</span></strong><span style=\"font-size:12.0pt\"><strong> Incorrect</strong> as <strong>Tegaserod</strong> is a <strong>5-HT4 receptor partial agonist,</strong> primarily<strong> used for the treatment </strong>of <strong>constipation-predominant irritable bowel syndrome (IBS-C)</strong>, not diarrhea.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Mosapride:</span></strong><span style=\"font-size:12.0pt\"><strong> Incorrect</strong> because <strong>Mosapride is a 5-HT4 agonist</strong> used to enhance <strong>gastrointestinal motility</strong>, commonly prescribed for conditions like<strong> GERD</strong> and<strong> functional dyspepsia, </strong>but not specifically for IBS-D.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Alosetron</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">&nbsp;It is approved for the <strong>treatment of diarrhea predominant lBS in women.</strong></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">&nbsp;It is more potent<strong> antagonist of the 5-HT3 receptor</strong> than ondansetron.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">&nbsp;It shows significant<strong> improvements</strong> in <strong>abdominal pain</strong> as well as <strong>stool frequency,</strong> <strong>consistency </strong>and<strong> urgency</strong> in lBS patients.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">&nbsp;It also <strong>diminishes</strong> <strong>visceral sensitivity</strong> and<strong> slow colonic transit.</strong></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Its<strong> major adverse effect</strong> is<strong> high</strong> incidence of development of <strong>ischemic colitis.</strong></span></span></span></li>\r\n</ul>",
      "correct_choice_id": 33179,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 8304,
      "choices": [
        {
          "id": 33183,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Available as enteric coated tablets</span></span></span></p>"
        },
        {
          "id": 33184,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Acts from the luminal side of gastric parietal cells</span></span></span></p>"
        },
        {
          "id": 33185,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Inactive at neutral pH</span></span></span></p>"
        },
        {
          "id": 33186,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Should be taken on empty stomach</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Identify the incorrect statement regarding proton pump inhibitors:</span></span></span></p>",
      "unique_key": "Q7124547",
      "question_audio": null,
      "question_video": null,
      "map_id": 36321,
      "difficulty_level": "intermediate",
      "subjects_id": [
        4
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. B) Acts from the luminal side of gastric parietal cells</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The<strong> incorrect</strong> statement regarding <strong>proton pump inhibitors </strong>is that they act from the <strong>luminal side of gastric parietal cells.</strong> This is <strong>false</strong> because<strong> PPIs such as omeprazole</strong> need to be <strong>absorbed into the bloodstream from the intestine</strong> and subsequently<strong> diffuse into the</strong> <strong>parietal cells</strong> where they get<strong> concentrated</strong> in the<strong> acidic pH of the canaliculi.</strong> The reason they concentrate there is that the<strong> charged</strong> <strong>forms generated in the canaliculi </strong>are <strong>unable to diffuse </strong>back into the bloodstream. In these canaliculi, <strong>PPIs convert</strong> into their <strong>active</strong> <strong>forms</strong> and <strong>covalently bind to the H+/K+ ATPase enzyme,</strong> leading to its <strong>irreversible inhibition.</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Available as enteric coated tablets:</span></strong><span style=\"font-size:12.0pt\"> This statement is <strong>correct</strong>. All <strong>PPIs</strong> are administered <strong>orally </strong>in <strong>enteric coated form</strong> to <strong>protect</strong> them <strong>from molecular transformation in the acidic gastric juice.</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Inactive at neutral pH:</span></strong><span style=\"font-size:12.0pt\"> This statement is<strong> correct.</strong> Omeprazole is<strong> inactive </strong>at <strong>neutral pH</strong>, but at<strong> pH less than 5, </strong>it rearranges to <strong>two charged cationic forms </strong>(a <strong>sulphenic acid</strong> and a<strong> sulphenamide configurations</strong>) that react<strong> covalently with SH groups </strong>of the <strong>H+K+ATPase enzyme</strong> and<strong> inactivate it irreversibly.</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Should be taken on an empty stomach:</span></strong><span style=\"font-size:12.0pt\"> This statement is<strong> correct.</strong> <strong>Bioavailability </strong>of a<strong>ll PPIs is reduced</strong> by <strong>food;</strong> they should be taken on an <strong>empty stomach,</strong> followed <strong>1 hour later</strong> by a meal to <strong>activate the H+K+ ATPase</strong> and make it <strong>more susceptible to</strong> <strong>the PPI.</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational Objective</span></u></strong><strong><u><span style=\"font-size:12.0pt\">:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><strong>Proton pump inhibitors </strong>should be <strong>administered on an empty stomach</strong> to ensure<strong> maximum absorption and effectiveness</strong>. This should be followed by <strong>a meal an hour later to enhance the activation of gastric acid pumps,</strong> making them<strong> more susceptible</strong> to <strong>inhibition by the drug.</strong></span></span></span></p>",
      "correct_choice_id": 33184,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 8305,
      "choices": [
        {
          "id": 33187,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">PPI</span></span></span></p>"
        },
        {
          "id": 33188,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Amoxicillin</span></span></span></p>"
        },
        {
          "id": 33189,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Tetracycline</span></span></span></p>"
        },
        {
          "id": 33190,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Clarithromycin</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Which of the following drugs are not included in triple drug regimen for H. pylori associated peptic ulcer disease? </span></span></span></p>",
      "unique_key": "Q7076159",
      "question_audio": null,
      "question_video": null,
      "map_id": 36322,
      "difficulty_level": "beginner",
      "subjects_id": [
        4
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. C) Tetracycline</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option C:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><strong>Tetracycline</strong> is<strong> not </strong>included in the commonly used<strong> triple drug regimen</strong> for treating<strong> Helicobacter pylori-associated peptic</strong> <strong>ulcer disease</strong>. (While, <strong>Tetracycline</strong> is <strong>not</strong> included in the<strong> triple regimen, </strong>but it is <strong>used in the quadruple therapy,</strong> aimed at cases where <strong>triple therapy may fail or is not suitable)</strong>.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The standard triple therapy consists of<strong> two antibiotics and a proton pump inhibitor (PPI).</strong> This combination is <strong>effective in</strong> e<strong>radicating H. pylori </strong>and allowing the<strong> ulcer to heal</strong> by <strong>reducing gastric acid secretion </strong>and directly <strong>targeting the bacteria.</strong></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The US-FDA approved<strong> triple drug regimen</strong> is:<strong> Lansoprazole 30 mg + Amoxicillin 1000 mg + clarithromycin 500 mg, all</strong> given <strong>twice daily for 2 weeks.</strong></span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. PPI:</span></strong><span style=\"font-size:12.0pt\"> <strong>Incorrect </strong>because<strong> proton pump inhibitors (such as Lansoprazole) </strong>are a crucial component of the<strong> triple therapy</strong> regimen, aiding in<strong> reducing gastric acid secretion</strong> to create a<strong> less acidic environment </strong>which enhances the <strong>effectiveness of antibiotics</strong>.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Amoxicillin:</span></strong><span style=\"font-size:12.0pt\"><strong> Incorrect </strong>as Amoxicillin is<strong> one of the antibiotics </strong>recommended in the<strong> triple therapy</strong>, working by<strong> inhibiting the</strong> <strong>cell wall synthesis</strong> of<strong> H. pylori bacteria.</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Clarithromycin:</span></strong><span style=\"font-size:12.0pt\"> <strong>Incorrect</strong> because <strong>Clarithromycin</strong> is included in the regimen and works by <strong>inhibiting protein synthesis of H. pylori</strong>, effectively <strong>helping</strong> in its<strong> eradication.</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/03/screenshot-2024-05-03-114045.png\" style=\"height:334px; width:1000px\" /></span></u></strong></span></span></p>",
      "correct_choice_id": 33189,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 8306,
      "choices": [
        {
          "id": 33191,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">5 HT3 antagonism resulting in decreased stimulation of extrinsic primary afferent neurons</span></span></span></p>"
        },
        {
          "id": 33192,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">5 HT1P antagonism resulting in decreased stimulation of intrinsic primary afferent neurons</span></span></span></p>"
        },
        {
          "id": 33193,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">5 HT4 agonism resulting in increased CGRP release and enhanced motility</span></span></span></p>"
        },
        {
          "id": 33194,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Stimulation of type 2 chloride channel in small intestine increasing the volume of luminal contents.</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following best describes the rationale of prucalopride in management of constipation dominant IBS? </span></span></p>",
      "unique_key": "Q5014582",
      "question_audio": null,
      "question_video": null,
      "map_id": 36323,
      "difficulty_level": "intermediate",
      "subjects_id": [
        4
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. C) 5 HT4 agonism resulting in increased CGRP release and enhanced motility</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option C:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><strong>Prucalopride </strong>is a<strong> selective 5-HT4 receptor agonist</strong> that enhances <strong>intestinal motility </strong>and <strong>transit</strong> by <strong>stimulating</strong> the release of <strong>acetylcholine and other neurotransmitters</strong>. This mechanism of action makes it<strong> effective in the treatment</strong> of <strong>chronic constipation, </strong>especially in patients with <strong>constipation-predominant irritable bowel syndrome (IBS-C).</strong></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">By <strong>activating 5-HT4 receptors </strong>on enteric neurons, prucalopride<strong> increases the release of calcitonin gene-related peptide</strong> <strong>(CGRP) </strong>and other <strong>neurotransmitters</strong>, resulting in <strong>enhanced peristalsis and transit.</strong></span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. 5 HT3 antagonism resulting in decreased stimulation of extrinsic primary afferent neurons:</span></strong><span style=\"font-size:12.0pt\"><strong> Incorrect as 5-HT3</strong> <strong>antagonists</strong> are primarily used in the management of <strong>diarrhea-predominant IBS (IBS-D), </strong>where they help by <strong>reducing gut motility</strong> <strong>and fluid secretion.</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. 5 HT1P antagonism resulting in decreased stimulation of intrinsic primary afferent neurons:</span></strong><span style=\"font-size:12.0pt\"> <strong>Incorrect </strong>because there is<strong> no</strong> recognized<strong> 5-HT1P receptor</strong> in current<strong> serotonin receptor </strong>classification relevant to <strong>IBS management.</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Stimulation of type 2 chloride channel in small intestine increasing the volume of luminal contents:</span></strong><span style=\"font-size:12.0pt\"> <strong>Incorrect </strong>as this describes the <strong>action of lubiprostone</strong>, not prucalopride.<strong> Lubiprostone </strong>works by <strong>activating type 2 chloride channels</strong>, leading to <strong>increased intestinal fluid secretion and stool passage.</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><strong>Prucalopride </strong>enhances <strong>gastrointestinal motility through 5-HT4 agonism,</strong> which<strong> increases neurotransmitter </strong>release, notably<strong> CGRP,</strong> promoting enhanced <strong>peristalsis</strong> and<strong> improving </strong>symptoms of<strong> constipation-dominant IBS.</strong></span></span></span></p>",
      "correct_choice_id": 33193,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 8307,
      "choices": [
        {
          "id": 33195,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Castor oil</span></span></span></p>"
        },
        {
          "id": 33196,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Docusate</span></span></span></p>"
        },
        {
          "id": 33197,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Mineral oil</span></span></span></p>"
        },
        {
          "id": 33198,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Loperamide</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">A 27-year-old woman who is 34 weeks pregnant is on bed rest and visits her obstetrician. During the visit, she informs her physician that she has been experiencing mild constipation. Which of the following medications will most likely be recommended to her? </span></span></span></p>",
      "unique_key": "Q9526347",
      "question_audio": null,
      "question_video": null,
      "map_id": 36324,
      "difficulty_level": "intermediate",
      "subjects_id": [
        4
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. B) Docusate</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><strong>Docusate</strong> is often recommended for managing <strong>mild constipation </strong>in <strong>pregnant women</strong> because it is considered<strong> safe and effective.</strong> It <strong>acts as a stool softener</strong> by <strong>increasing the amount of water the stool absorbs </strong>in the gut, making the <strong>stool softer</strong> and <strong>easier to pass.</strong> Its <strong>safety </strong>profile during <strong>pregnancy </strong>makes it a preferable<strong> choice for constipation relief.</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><u><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Explanation:</span></strong></span></span></u></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Castor oil:</span></strong><span style=\"font-size:12.0pt\"><strong> Incorrect </strong>because <strong>castor oil</strong> is generally<strong> not</strong> recommended during <strong>pregnancy</strong>. It can <strong>trigger uterine</strong> <strong>contractions</strong>, which may<strong> pose risks to the fetus.</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Mineral oil:</span></strong><span style=\"font-size:12.0pt\"> <strong>Incorrect </strong>as mineral oil is also <strong>not</strong> recommended during <strong>pregnancy</strong>. It can <strong>decrease the absorption of fat-</strong>s<strong>oluble vitamins</strong>, which are <strong>crucial for fetal development.</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Loperamide:</span></strong><span style=\"font-size:12.0pt\"><strong> Incorrect</strong> because <strong>loperamide</strong> is an<strong> anti-diarrheal medication, not </strong>a treatment for<strong> constipation.</strong> It works by <strong>slowing down gut movement,</strong> which would be <strong>counterproductive</strong> in the treatment of <strong>constipation.</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational Objective:</span></u></strong><u> </u></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><strong>Docusate</strong> is commonly recommended for<strong> treating constipation </strong>in<strong> pregnant women </strong>due to<strong> its efficacy and safety profile</strong>. It<strong> helps</strong> <strong>soften stools without </strong>the risks associated with<strong> other laxatives like castor oil and mineral oil</strong>, which can adversely affect<strong> pregnancy.</strong></span></span></span></p>",
      "correct_choice_id": 33196,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 8308,
      "choices": [
        {
          "id": 33199,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Calcium citrate</span></span></span></p>"
        },
        {
          "id": 33200,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Famotidine</span></span></span></p>"
        },
        {
          "id": 33201,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Omeprazole</span></span></span></p>"
        },
        {
          "id": 33202,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ranitidine</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">An elderly woman with a recent history of myocardial infarction is seeking a medication to</span></span><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> help treat her occasional heartburn. She is currently taking several medications, including aspirin, clopidogrel, simvastatin, metoprolol, and lisinopril. Which of the following choices should be avoided in this patient? </span></span></p>",
      "unique_key": "Q4637747",
      "question_audio": null,
      "question_video": null,
      "map_id": 36325,
      "difficulty_level": "intermediate",
      "subjects_id": [
        4
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. C) Omeprazole</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C: </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><strong>Omeprazole</strong> should be <strong>avoided</strong> in this patient because it is a<strong> proton pump inhibitor (PPI) </strong>that can <strong>inhibit the enzyme CYP2C19.</strong> <strong>Clopidogrel</strong>, a medication the patient is taking, <strong>relies on CYP2C19</strong> for its<strong> conversion</strong> into its <strong>active form.</strong> <strong>Inhibition of this enzyme</strong> by <strong>omeprazole</strong> can <strong>reduce the effectiveness of clopidogrel</strong>, which is critical for <strong>preventing clot formation </strong>following a<strong> myocardial</strong> <strong>infarction</strong>. This<strong> interaction </strong>could potentially <strong>increase the risk of another cardiac event.</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Calcium citrate:</span></strong><span style=\"font-size:12.0pt\"> This option is considered <strong>safe for treating heartburn </strong>and <strong>does not interact </strong>adversely with <strong>clopidogrel or</strong> the <strong>other medications</strong> the patient is taking.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Famotidine:</span></strong><span style=\"font-size:12.0pt\"> Famotidine is an <strong>H2-receptor antagonist </strong>and <strong>does not </strong>interfere with the<strong> CYP2C19 enzyme,</strong> making it a <strong>safe</strong> option for this patient.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Ranitidine:</span></strong><span style=\"font-size:12.0pt\"> Although ranitidine is also an<strong> H2-receptor antagonist,</strong> it has been found to be<strong> safe in terms</strong> of not significantly affecting the<strong> metabolism of clopidogrel like omeprazole does.</strong> However, due to other concerns such as <strong>potential NDMA</strong> <strong>contamination,</strong> <strong>ranitidine</strong> has been <strong>recalled in many markets.</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">While treating <strong>heartburn in patients</strong> on <strong>multiple medications,</strong> especially those on <strong>clopidogrel post-myocardial infarction, </strong>it is important to<strong> avoid proton pump inhibitors </strong>like <strong>omeprazole</strong> due to their potential to <strong>inhibit CYP2C19 </strong>and <strong>reduce </strong>the effectiveness of <strong>clopidogrel</strong>, thereby<strong> increasing the risk of cardiovascular events.</strong></span></span></span></p>",
      "correct_choice_id": 33201,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 8309,
      "choices": [
        {
          "id": 33203,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ondansetron</span></span></span></p>"
        },
        {
          "id": 33204,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Dexamethasone</span></span></span></p>"
        },
        {
          "id": 33205,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Metoclopramide</span></span></span></p>"
        },
        {
          "id": 33206,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Dronabinol</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In emergency department, an intern gave an anti-emetic drug to a patient and the patient</span></span><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> then developed abnormal posture and torticollis. Most likely drug is? </span></span></p>",
      "unique_key": "Q6301715",
      "question_audio": null,
      "question_video": null,
      "map_id": 36326,
      "difficulty_level": "beginner",
      "subjects_id": [
        4
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. C) Metoclopramide</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><strong>Metoclopramide</strong> is the most likely drug that caused the patient to develop <strong>abnormal posture and torticollis.</strong> This drug is a <strong>dopamine</strong> <strong>D2 receptor antagonist</strong> that<strong> enhances gastrointestinal motility</strong> but also has a <strong>known side effect </strong>profile that includes<strong> extrapyramidal</strong> symptoms such as<strong> dystonia</strong>. <strong>Dystonia</strong> is a<strong> specific type</strong> of movement disorder characterized by<strong> involuntary muscle contractions,</strong> which can result in<strong> twisting and repetitive movements or abnormal postures</strong>, such as <strong>torticollis (twisting of the neck).</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Ondansetron:</span></strong><span style=\"font-size:12.0pt\"><strong> Incorrect</strong> because <strong>Ondansetron is a 5-HT3 receptor antagonist </strong>that is generally <strong>used to prevent nausea and</strong> <strong>vomiting </strong>associated with <strong>cancer chemotherapy and surgery </strong>and <strong>does not </strong>typically cause <strong>extrapyramidal side effects.</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Dexamethasone</span></strong><span style=\"font-size:12.0pt\">: <strong>Incorrect </strong>as Dexamethasone is a<strong> corticosteroid </strong>used as an <strong>antiemetic in chemotherapy s</strong>ettings. It works by<strong> reducing inflammation</strong> and <strong>does not</strong> cause<strong> extrapyramidal symptoms.</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Dronabinol:</span></strong><span style=\"font-size:12.0pt\"> <strong>Incorrect</strong> because<strong> Dronabinol</strong> is a <strong>cannabinoid receptor agonist </strong>used to treat<strong> nausea and vomiting </strong>caused by <strong>chemotherapy </strong>and to<strong> stimulate appetite.</strong> Its side effects may include<strong> dysphoria, dizziness, and ataxia</strong> but<strong> not dystonia or torticollis.</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><strong>Metoclopramide</strong>, while effective as an <strong>antiemetic and for promoting gastric motility</strong>, can cause<strong> extrapyramidal </strong>symptoms such as <strong>dystonia </strong>due to its<strong> antagonistic effects</strong> on<strong> dopamine</strong> <strong>D2 receptors</strong>. These effects are <strong>important to monitor, </strong>especially in <strong>emergency</strong> settings.</span></span></span></p>",
      "correct_choice_id": 33205,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 8310,
      "choices": [
        {
          "id": 33207,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\">Linaclotide</span></span></span></p>"
        },
        {
          "id": 33208,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\">Crofelemer</span></span></span></p>"
        },
        {
          "id": 33209,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\">Alvimopan</span></span></span></p>"
        },
        {
          "id": 33210,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Prucalopride</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Which one of the following is the CFTR channel inhibitor? </span></span></span></p>",
      "unique_key": "Q6615210",
      "question_audio": null,
      "question_video": null,
      "map_id": 36327,
      "difficulty_level": "difficult",
      "subjects_id": [
        4
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. B) Crofelemer</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option B:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><strong>Crofelemer </strong>is the <strong>CFTR channel inhibitor</strong>. It is used for the <strong>symptomatic relief of non-infectious diarrhea</strong> in adult patients with <strong>HIV/AIDS who are on anti-retroviral therapy.</strong> It works by <strong>inhibiting the chloride secretion </strong>into the i<strong>ntestinal lumen </strong>through the cystic fibrosis transmembrane conductance regulator (CFTR) chloride ion channel.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A.&nbsp; Linaclotide:</span></strong><span style=\"font-size:12.0pt\"> Linaclotide is a <strong>guanylate cyclase-C agonist </strong>used in the treatment of<strong> irritable bowel syndrome </strong>with <strong>constipation</strong> and<strong> chronic idiopathic constipation</strong>. It works by <strong>increasing the secretion of chloride and bicarbonate ions</strong> in the intestine, leading to<strong> increased fluid secretion</strong> and <strong>accelerated gastrointestinal transit time.</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Alvimopan:</span></strong><span style=\"font-size:12.0pt\"> Alvimopan is a peripherally acting <strong>mu-opioid receptor antagonist </strong>used to treat <strong>postoperative ileus.</strong> It works by <strong>blocking the action of opioids </strong>on the<strong> mu-opioid receptor</strong> in the <strong>gastrointestinal tract,</strong> which can <strong>reduce gastrointestinal motility</strong> and cause <strong>constipation.</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Prucalopride</span></strong><span style=\"font-size:12.0pt\">: Prucalopride is a<strong> selective serotonin type 4 (5-HT4) receptor agonist</strong> used in the treatment of <strong>chronic</strong> <strong>idiopathic constipation</strong>. It works by <strong>stimulating colonic motility</strong> and <strong>accelerating gastrointestinal transit time,</strong> which can lead to <strong>increased bowel movements.</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><strong>Crofelemer</strong> is unique as a<strong> CFTR channel inhibitor, </strong>making it effective in <strong>treating diarrhea by reducing chloride and water secretion</strong> into the<strong> intestines</strong>, which <strong>contrasts</strong> with <strong>other options</strong> that primarily affect <strong>motility or opioid receptor antagonism.</strong></span></span></span></p>",
      "correct_choice_id": 33208,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 8311,
      "choices": [
        {
          "id": 33211,
          "text": "<p style=\"margin-left:6px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Omeprazole</span></span></span></p>"
        },
        {
          "id": 33212,
          "text": "<p style=\"margin-left:6px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ranitidine</span></span></span></p>"
        },
        {
          "id": 33213,
          "text": "<p style=\"margin-left:6px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Pirenzepine</span></span></span></p>"
        },
        {
          "id": 33214,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Misoprostol</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Selective M1 antagonist used in Gastric ulcer is?</span></span></span></p>",
      "unique_key": "Q9115854",
      "question_audio": null,
      "question_video": null,
      "map_id": 36328,
      "difficulty_level": "beginner",
      "subjects_id": [
        4
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. C) Pirenzepine</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><strong>Pirenzepine</strong> is a selective <strong>M1 muscarinic receptor antagonist </strong>that is used in the treatment of <strong>peptic ulcers</strong>. By <strong>selectively blocking</strong> <strong>M1 receptors</strong>, Pirenzepine<strong> reduces gastric acid secretion</strong> by about<strong> 40-50%</strong>, which helps to manage the <strong>symptoms and healing</strong> process of<strong> gastric ulcers without</strong> producing many of the <strong>side effects</strong> typically associated with <strong>non-selective anticholinergics. T</strong>his targeted action makes<strong> Pirenzepine effective in ulcer management</strong> while <strong>minimizing adverse effects </strong>on <strong>other muscarinic receptor</strong> subtypes found throughout the body.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Omeprazole:</span></strong><span style=\"font-size:12.0pt\"> <strong>Incorrect</strong> because <strong>Omeprazole is a proton pump inhibitor (PPI) </strong>that works by<strong> irreversibly blocking</strong> the <strong>hydrogen/potassium ATPase enzyme in the stomach</strong>, leading to a significant <strong>reduction in gastric acid secretion. </strong>It <strong>does not </strong>act as a <strong>muscarinic antagonist.</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Ranitidine:</span></strong><span style=\"font-size:12.0pt\"> <strong>Incorrect</strong> as Ranitidine is an<strong> H2 blocker</strong> that<strong> competitively inhibits</strong> <strong>histamine </strong>at<strong> H2 receptors on parietal cells,</strong> thereby <strong>decreasing gastric acid secretion</strong>. It is not a muscarinic antagonist.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Misoprostol:</span></strong><span style=\"font-size:12.0pt\"> <strong>Incorrect </strong>because Misoprostol is a<strong> mucosal protectant</strong> used primarily to <strong>prevent gastric ulcers </strong>caused by <strong>nonsteroidal anti-inflammatory drugs (NSAIDs) </strong>by<strong> mimicking</strong> the action of<strong> prostaglandins</strong>. It <strong>does not</strong> involve <strong>muscarinic receptor</strong> <strong>antagonism.</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/03/screenshot-2024-05-03-120507.png\" style=\"height:627px; width:1000px\" /></span></u></strong></span></span></p>",
      "correct_choice_id": 33213,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 8312,
      "choices": [
        {
          "id": 33215,
          "text": "<p style=\"margin-left:6px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Liquid paraffin</span></span></span></p>"
        },
        {
          "id": 33216,
          "text": "<p style=\"margin-left:6px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Senna</span></span></span></p>"
        },
        {
          "id": 33217,
          "text": "<p style=\"margin-left:6px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Bisacodyl</span></span></span></p>"
        },
        {
          "id": 33218,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Psyllium</span></span></span></p>"
        }
      ],
      "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 45-year-old woman has been complaining of chronic constipation for several months. She</span></span><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> has been taking a laxative regularly for relief. She underwent colonoscopy which reveals the</span></span><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> presence of dark black discoloration of colon (melanosis coli). Which of the following medications is most likely causing this discoloration of the colon?</span></span></p>",
      "unique_key": "Q3777985",
      "question_audio": null,
      "question_video": null,
      "map_id": 36329,
      "difficulty_level": "beginner",
      "subjects_id": [
        4
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. B) Senna</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><strong>Melanosis coli </strong>is a <strong>benign</strong> condition characterized by <strong>a dark pigmentation of the colon&#39;s mucosa, </strong>commonly associated with the <strong>chronic use of laxatives </strong>containing <strong>anthraquinones</strong>, such as <strong>senna.</strong> The <strong>dark coloration </strong>results from the<strong> accumulation of a lipofuscin-</strong>like <strong>pigment in the colon,</strong> which is derived from the <strong>oxidation of these anthraquinone compounds</strong>. While <strong>melanosis coli</strong> is<strong> asymptomatic</strong> and primarily a<strong> cosmetic concern</strong>, it serves as an<strong> indicator of prolonged laxative use </strong>and may necessitate a re-evaluation of bowel management strategies.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Liquid paraffin:</span></strong><span style=\"font-size:12.0pt\"><strong> Incorrect </strong>because <strong>liquid paraffin,</strong> a <strong>lubricant laxative</strong>, <strong>does not</strong> cause <strong>melanosis coli.</strong> It works by coating the<strong> stool and the gut,</strong> <strong>easing</strong> the <strong>passage of stool</strong> without affecting the mucosa&#39;s pigmentation.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Bisacodyl:</span></strong><span style=\"font-size:12.0pt\"><strong> Incorrect </strong>as <strong>bisacodyl, </strong>a <strong>stimulant laxative, </strong>primarily induces <strong>bowel movements by stimulating nerve endings </strong>in the<strong> colon wall</strong> but is<strong> not</strong> linked to the <strong>development of melanosis coli.</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Psyllium:</span></strong><span style=\"font-size:12.0pt\"> <strong>Incorrect </strong>because<strong> psyllium</strong>, a<strong> bulk-forming laxative</strong>, <strong>absorbs water</strong> in the <strong>intestine to form a viscous liquid </strong>that <strong>promotes bowel movements.</strong> It<strong> does not</strong> cause <strong>discoloration of the colon&#39;s mucosa.</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational Objective:</span></u></strong><u> </u></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><strong>Senna</strong>, an <strong>anthraquinone-containing laxative,</strong> is associated with<strong> melanosis coli,</strong> a <strong>benign</strong> condition marked by <strong>dark pigmentation of</strong> the <strong>colon.</strong> This condition highlights the need to <strong>reassess and possibly</strong> adjust <strong>chronic constipation management.</strong></span></span></span></p>",
      "correct_choice_id": 33216,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 8313,
      "choices": [
        {
          "id": 33219,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Lubiprostone</span></span></span></p>"
        },
        {
          "id": 33220,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Linaclotide</span></span></span></p>"
        },
        {
          "id": 33221,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Alosetron</span></span></span></p>"
        },
        {
          "id": 33222,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Prucalopride</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">All of the following drugs are used for constipation dominant IBS except?<em> </em></span></span></p>",
      "unique_key": "Q7986389",
      "question_audio": null,
      "question_video": null,
      "map_id": 36330,
      "difficulty_level": "intermediate",
      "subjects_id": [
        4
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. C) Alosetron</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><strong>Alosetron </strong>is used primarily for<strong> diarrhea-dominant irritable bowel syndrome (IBS-D) </strong>and<strong> not</strong> for <strong>constipation-dominant IBS (IBS-C)</strong>. It functions as a<strong> 5-HT3 antagonist</strong>,<strong> reducing the activity of serotonin </strong>in the gut which <strong>helps to slow bowel movements</strong> and <strong>alleviate</strong> <strong>diarrhea</strong>. Its use is specifically<strong> indicated for women with severe IBS-D </strong>that has not responded to other treatments.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Lubiprostone:</span></strong><span style=\"font-size:12.0pt\"> <strong>Incorrect</strong> because Lubiprostone is indeed used for <strong>constipation-dominant IBS. </strong>It is a<strong> chloride channel</strong> <strong>activator </strong>that <strong>increases fluid secretion in the intestine</strong>, which<strong> facilitates stool passage and alleviates constipation.</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Linaclotide:</span></strong><span style=\"font-size:12.0pt\"><strong> Incorrect </strong>as Linaclotide is <strong>used for IBS-C</strong>. It is a <strong>guanylate cyclase-C agonist</strong> that<strong> increases both chloride and</strong> <strong>bicarbonate secretion</strong> into the<strong> intestine</strong>, enhancing<strong> fluid secretion and improving bowel movement.</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Prucalopride:</span></strong><span style=\"font-size:12.0pt\"> <strong>Incorrect</strong> because <strong>Prucalopride is a 5-HT4 agonist </strong>that enhances <strong>gastrointestinal motility, </strong>making it suitable for treating<strong> IBS-C by accelerating transit </strong>time through the<strong> colon.</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Drugs Used in IBS</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/03/screenshot-2024-05-03-121117.png\" style=\"height:322px; width:1000px\" /></span></strong></span></span></p>",
      "correct_choice_id": 33221,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 8314,
      "choices": [
        {
          "id": 33223,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">CYP2C10</span></span></span></p>"
        },
        {
          "id": 33224,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">CYPA2</span></span></span></p>"
        },
        {
          "id": 33225,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">CYP2C19</span></span></span></p>"
        },
        {
          "id": 33226,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">CYP2C20</span></span></span></p>"
        }
      ],
      "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Anti-Platelet therapy is usually given for patients with stroke, MI and peripheral vascular disease. PPIs are frequently administered along with these drugs to prevent the risk of increased gastrointestinal erosions and bleeding. The interaction between clopidogrel and PPI has recently been given much attention due to its clinical significance. The metabolizing enzyme common to these two drugs is? </span></span></p>",
      "unique_key": "Q1781436",
      "question_audio": null,
      "question_video": null,
      "map_id": 36331,
      "difficulty_level": "beginner",
      "subjects_id": [
        4
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. C) CYP2C19</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><strong>CYP2C19</strong> is the enzyme responsible for the<strong> conversion of clopidogrel into its active form.</strong> This enzyme&#39;s activity is crucial for <strong>clopidogrel&#39;s effectiveness as an antiplatelet agent</strong>.<strong> Proton pump inhibitors (PPIs),</strong> especially<strong> omeprazole and esomeprazole</strong>, are known to<strong> inhibit CYP2C19</strong>, which can lead to<strong> decreased activation of clopidogrel.</strong> This interaction is clinically significant because it can potentially <strong>reduce the efficacy of clopidogrel,</strong> thereby<strong> increasing the risk of adverse cardiovascular events </strong>in patients who rely on<strong> clopidogrel</strong> for its<strong> antiplatelet effects.</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. CYP2C10:</span></strong><span style=\"font-size:12.0pt\"> <strong>Incorrect</strong> as <strong>CYP2C10 </strong>is <strong>not </strong>a recognized enzyme in the<strong> cytochrome P450 </strong>family that is <strong>relevant to clopidogrel or PPI metabolism.</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. CYPA2:</span></strong><span style=\"font-size:12.0pt\"><strong> Incorrect</strong> because <strong>CYPA2 does not </strong>exist. The <strong>cytochrome P450 enzymes </strong>are typically designated with a<strong> format</strong> starting with <strong>CYP </strong>followed by<strong> numbers and letters (e.g., CYP2C19).</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. CYP2C20:</span></strong><span style=\"font-size:12.0pt\"><strong> Incorrect</strong> as<strong> CYP2C20</strong> is<strong> not </strong>an established member of the<strong> cytochrome P450 enzyme family</strong> involved in the metabolism of <strong>clopidogrel or PPIs.</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational Objective:</span></u></strong><u> </u></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><strong>CYP2C19 </strong>is the key enzyme involved in the <strong>activation of clopidogrel </strong>and that certain <strong>PPIs, such as omeprazole and esomeprazole</strong>, can <strong>inhibit this enzyme</strong>, potentially<strong> reducing the antiplatelet activity of clopidogrel</strong>. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><strong>Awareness of this interaction </strong>is<strong> crucial </strong>when managing patients who <strong>require both antiplatelet and gastric protective therapies.</strong></span></span></span></p>",
      "correct_choice_id": 33225,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 8315,
      "choices": [
        {
          "id": 33227,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">5HT4-agonist </span></span></span></p>"
        },
        {
          "id": 33228,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">D2 blocker</span></span></span></p>"
        },
        {
          "id": 33229,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Macrolides </span></span></span></p>"
        },
        {
          "id": 33230,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Diphenoxymethane</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following is not a prokinetic drug? </span></span></p>",
      "unique_key": "Q8868140",
      "question_audio": null,
      "question_video": null,
      "map_id": 36332,
      "difficulty_level": "beginner",
      "subjects_id": [
        4
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. D) Diphenoxymethane</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><strong>Diphenoxymethane</strong> is<strong> not a prokinetic drug; </strong>it is the <strong>active metabolite of diphenoxylate, </strong>which functions primarily as an <strong>anti-diarrheal medication</strong>. It works by <strong>slowing intestinal motility </strong>through its action as a <strong>mu-opioid receptor agonist </strong>in the intestinal wall. This <strong>leads to increased intestinal transit time</strong> and<strong> decreased fluid secretion,</strong> which are<strong> effects opposite </strong>to those<strong> desired from<strong> </strong>prokinetic agents.</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. 5HT4-agonist:</span></strong><span style=\"font-size:12.0pt\"> <strong>Incorrect </strong>as<strong> 5HT4-agonists</strong>, such as<strong> mosapride, tegaserod, and prucalopride,</strong> are indeed <strong>prokinetic drugs.</strong> They<strong> stimulate peristalsis</strong> and <strong>increase gastric emptying</strong> by acting on the<strong> 5HT4 receptors in the gastrointestinal tract.</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. D2 blocker:</span></strong><span style=\"font-size:12.0pt\"><strong> Incorrect</strong> because<strong> D2 blockers</strong> like <strong>metoclopramide and domperidone </strong>are used as <strong>prokinetic drugs</strong> due to their <strong>ability to enhance gastrointestinal motility</strong> by <strong>blocking dopamine receptors, </strong>which promotes<strong> gastric emptying</strong> and <strong>decreases</strong> <strong>nausea and vomiting.</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Macrolides:</span></strong><span style=\"font-size:12.0pt\"><strong> Incorrect </strong>as certain macrolides, such as<strong> erythromycin</strong>, act as <strong>motilin receptor agonists</strong> in the gut and are used for their <strong>prokinetic effects to stimulate gastric motility.</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></span></u></strong></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/03/screenshot-2024-05-03-121706.png\" style=\"height:584px; width:1000px\" /></p>",
      "correct_choice_id": 33230,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    }
  ]
}